Following the progress of pharmaceutical mixing studies using near-infrared spectroscopy

Significance of the Topic

The homogeneity of solid pharmaceutical blends is a critical quality attribute that directly impacts dosage accuracy, product safety and regulatory compliance. Traditional grab‐sampling followed by off‐line HPLC or UV–Vis assays is laborious and time‐consuming. Near‐infrared (NIR) spectroscopy offers a rapid, non‐destructive alternative for monitoring blend uniformity in real time, enabling more efficient process development and enhanced process control.

Objectives and Study Overview

This application note evaluates the feasibility of using NIR spectral information to track and determine the endpoint of pharmaceutical mixing processes. Two approaches are compared:

• Visual overlay of second‐derivative spectra at successive mixing intervals.
• Quantitative spectral matching using a cosine‐similarity algorithm.

The model system comprises common excipients and actives to illustrate method performance in a laboratory mixing study.

Methodology

Samples of pharmaceutical grade lactose, talc, aspirin and vitamin B12 were blended in a stepwise cross‐transfer protocol. Each mix cycle (six total) generated four sub‐samples (A–D). Prior to NIR analysis each container was mixed to ensure representativity. Spectra were collected in reflectance mode over 400–2500 nm, averaging 32 scans per measurement. Second‐derivative processing minimized baseline effects due to particle size variations.

Instrumentation Used

• Foss NIRSystems Model 6500 NIR Spectrophotometer with sample transport system.
• Recommended replacement: NIRS XDS RapidContent Analyzer.

Main Results and Discussion

Method 1 (visual overlay): Early, middle, penultimate and final blends show progressive convergence of second‐derivative spectra, indicating improved homogeneity. This approach provides a fast screening tool but relies on subjective spectral comparison.

Method 2 (spectral matching): Each sample spectrum is treated as a normalized vector and compared to a reference blend via a dot‐product, yielding a match index (–1.0000 to 1.0000). As mixing proceeds, the index approaches 1.0000, providing an objective metric for endpoint determination. The algorithm demonstrated clear differentiation between incomplete and fully mixed samples.

Benefits and Practical Applications

• Substantial reduction in off‐line assay workload and time.
• Non‐destructive, near‐real‐time monitoring of blend uniformity.
• Objective determination of mixing endpoints increases reproducibility.
• Potential integration into quality‐by‐design and process analytical technology (PAT) frameworks.

Future Trends and Potential Applications

Advances in chemometrics and machine learning could further improve multicomponent quantification and blend prediction. In‐line NIR probes and automated feedback control loops will enable true continuous monitoring. Integration with process control systems and digital twins promises tighter process regulation, reduced waste and accelerated scale‐up in pharmaceutical manufacturing.

Conclusion

NIR spectroscopy, particularly when combined with spectral matching algorithms, offers a rapid, objective and non‐destructive approach for monitoring pharmaceutical mixing processes. Adoption of this method can significantly decrease development time and improve process understanding, although final regulatory assays for content uniformity remain necessary.

References

No external literature references were provided in the original application note.